Drug Shortages Reveal GMP Concerns

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-06-02-2002, Volume 26, Issue 6

FDA cites manufacturing difficulties as a main contributing factor to recent drug shortages, which mainly involve injectibles and vaccines.

Related Content:

Regulatory/GMP ComplianceQuality SystemsRegulatory WatchPharmaceutical Technology-06-02-2002
Susan Schniepp of Regulatory Compliance Associates Explores the Impact of QMS on Quality Maturity (INTERPHEX 2024)
Keynote Session Highlights Importance of Process Validation and Data Integrity (INTERPHEX 2024)
FDA Establishes Center for Clinical Trial Innovation